K Harada - Concepedia

Author

K Harada

Hiroshima University ORCID

Also Known As

K Harada, K. Harada, Kenji Harada

Publications

395

Citations

H-Index

Concepts

All Affiliations

Hiroshima University The University of Osaka Keio University Nagoya University

About

K Harada is an author at Hiroshima University specializing in medicine, cancer research, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	193
2	Pathology	3	3	115
3	Pharmacology	2	2	86
4	Cell Biology	1	1	62
5	Endocrinology	1	1	16

K Harada

Publications

289

Citations

H-Index

Page 1

	Year	Citations
Molecular biological analysis of 5-FU-resistant gastric cancer organoids; KHDRBS3 contributes to the attainment of features of cancer stem cell Shoichi Ukai, Ririno Honma, Naoya Sakamoto, Oncogene MedicineCancer Stem CellCancer GenomicsStem Cell ResearchCell Biology	2020	62
Six cases of central serous choroidopathy induced by systemic corticosteroid therapy Takeshi Harada, K Harada Documenta Ophthalmologica Six CasesCentral Serous ChoroidopathyChoroid PlexusSclerodermaSystemic Corticosteroid Therapy	1985	53
Schlafen 11 predicts response to platinum-based chemotherapy in gastric cancers Tsuyoshi Takashima, Daiki Taniyama, Naoya Sakamoto, British Journal of Cancer OncologyGastrointestinal OncologyMedicinePathologyCancer Treatment	2021	46
Establishment of oxaliplatin-resistant gastric cancer organoids: importance of myoferlin in the acquisition of oxaliplatin resistance K Harada, Naoya Sakamoto, Shoichi Ukai, Gastric Cancer Tumor BiologyOncologyChemoprevention StrategyOncogenic AgentMedicine	2021	40
KHDRBS3 promotes multi‐drug resistance and anchorage‐independent growth in colorectal cancer Shoichi Ukai, Naoya Sakamoto, Daiki Taniyama, Cancer Science	2021	29
Prognostic impact of Schlafen 11 in bladder cancer patients treated with platinum‐based chemotherapy Daiki Taniyama, Naoya Sakamoto, Tsuyoshi Takashima, Cancer Science Surgical OncologyCancer ManagementPathologyTumor BiologyOncology	2021	29
A super long-acting LH-RH analogue induces regression of hypothalamic hamartoma associated with precocious puberty K Harada, Junji Yoshida, Takashi Wakabayashi, Acta Neurochirurgica Developmental BiologyPituitary GlandEndocrine MechanismGrowth HormonePhysiology	1995	16
<scp>TDO2</scp> overexpression correlates with poor prognosis, cancer stemness, and resistance to cetuximab in bladder cancer Quốc Thắng Phạm, Daiki Taniyama, Shintaro Akabane, Cancer Reports	2021	14

Page 1